Jonathan S. Schulman
- Denver
- New York
Notice
Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.
Jonathan advises public companies in capital markets transactions and in connection with their SEC disclosure obligations and related corporate governance matters.
Jonathan Schulman represents clients in a variety of capital markets transactions, including initial public offerings, underwritten equity and debt offerings, Rule 144A debt offerings, convertible note offerings, and private placements. Jonathan serves as a trusted adviser to public companies on SEC reporting, compliance and disclosure issues, stock exchange rules, stockholder activism, and general corporate matters. He also represents public companies in M&A.
Areas of focus
Industries
Services
Education & Credentials
Education
- University of Virginia School of Law, J.D., Editorial Board, Virginia Law & Business Review, 2014
- University of Miami, B.B.A., Entrepreneurship, summa cum laude, 2010
Bar and Court Admissions
-
Colorado
-
New York
Related Employment
- Latham & Watkins LLP, New York, NY and Washington, D.C., Associate, 2014-2018
- Latham & Watkins LLP, New York, NY, Summer Associate, 2013
Professional Recognition
Recognized by Best Lawyers: Ones to Watch for Corporate Law, 2024-2026
Professional Experience
Public Company Representation
Jonathan provides ongoing public company representation to a number of public companies, including:
- Crocs, Inc.
- Everus Construction Group, Inc.
- Knife River Corporation
- MDU Resources Group, Inc.
- Molson Coors Beverage Company
- Pacira BioSciences, Inc.
Capital Markets & Corporate Finance
Amcor in over $5.5 billion of senior notes offerings
Amcor in its multibillion-dollar commercial paper programs
Crocs in $700 million of Rule 144A senior notes offerings
Crocs in a $244 million block trade of its common stock
MDU in its approximately $230 million follow-on offering of common stock with an equity forward
MDU in its up to $400 million ATM program with an equity forward
Pacira BioSciences in a $287.5 million Rule 144A offering of convertible senior notes
CAI International in multiple preferred stock and ATM offerings
Gevo in multiple follow-on common stock, warrant, and ATM offerings
Ideal Power in multiple follow-on offerings
The underwriters in multiple follow-on offerings of Fate Therapeutics
Representation of other various issuers and underwriters in connection with initial public offerings (IPOs), underwritten public offerings, at-the-market (ATM) offerings, private investment in public equity (PIPEs), private placements and other financing transactions
Mergers & Acquisitions
Crocs (Nasdaq: CROX) in its $2.5 billion acquisition of HEYDUDE
RadNet, Inc. (Nasdaq: RDNT) in its acquisition of iCAD, Inc. (Nadsaq: iCAD)
Pacira BioSciences (Nasdaq: PCRX) in its acquisition of Flexion Therapeutics (Nasdaq: FLXN)
Pacira BioSciences (Nasdaq: PCRX) in its acquisition of MyoScience
CAI International (NYSE: CAI) in its acquisition by Mitsubishi HC Capital
SMTC Corporation (Nasdaq: SMTX) in its acquisition by H.I.G. Capital
AeroGrow (OTC: AERO) in its acquisition by Scotts Miracle-Gro (NYSE: SMG)
Peak Resorts (Nasdaq: SKIS) in its acquisition by Vail Resorts (NYSE: MTN)
